CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dipyridodiazepine
Accession: CHEBI:63667
browse the term
Definition: An organic heterotricyclic compound whose skeleton consists of a diazepine ring which is fused to two pyridine rings.
Synonyms: related_synonym: dipyridodiazepines
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
EXP
Nevirapine results in increased expression of ABCB1A mRNA
CTD
PMID:23947594
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
decreases expression
EXP
Nevirapine metabolite results in decreased expression of ADAMTS9 mRNA; Nevirapine results in decreased expression of ADAMTS9 mRNA
CTD
PMID:23947594
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
G
Adgrf5
adhesion G protein-coupled receptor F5
increases expression
EXP
Nevirapine metabolite results in increased expression of ADGRF5 mRNA
CTD
PMID:23947594
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression increases secretion
ISO
Nevirapine results in increased expression of ADIPOQ mRNA Nevirapine results in increased secretion of ADIPOQ protein
CTD
PMID:21619898
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Aif1
allograft inflammatory factor 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of AIF1 mRNA
CTD
PMID:23947594
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Alb
albumin
affects binding
ISO
Nevirapine binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Apoa1
apolipoprotein A1
increases expression
ISO
Nevirapine results in increased expression of APOA1 protein
CTD
PMID:19667106
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Ar
androgen receptor
increases expression
ISO
Nevirapine results in increased expression of AR mRNA; Nevirapine results in increased expression of AR protein
CTD
PMID:19152342
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Armcx2
armadillo repeat containing, X-linked 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of ARMCX2 mRNA; Nevirapine results in decreased expression of ARMCX2 mRNA
CTD
PMID:23947594
NCBI chr X:97,980,662...97,985,523
Ensembl chr X:97,980,660...97,985,552
G
Arnt
aryl hydrocarbon receptor nuclear translocator
increases expression
EXP
Nevirapine metabolite results in increased expression of ARNT mRNA
CTD
PMID:23947594
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Nevirapine results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Cd36
CD36 molecule
increases expression
EXP
Nevirapine metabolite results in increased expression of CD36 mRNA
CTD
PMID:23947594
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
Nevirapine results in increased expression of CEBPA mRNA
CTD
PMID:21619898
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Ces2h
carboxylesterase 2H
increases expression
EXP
Nevirapine results in increased expression of CES2 mRNA
CTD
PMID:23947594
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Ciita
class II, major histocompatibility complex, transactivator
increases expression
ISO
Nevirapine results in increased expression of CIITA
CTD
PMID:26626330
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Clec4a1
C-type lectin domain family 4, member A1
decreases expression
EXP
Nevirapine results in decreased expression of CLEC4A1 mRNA
CTD
PMID:23947594
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec4a3
C-type lectin domain family 4, member A3
decreases expression
EXP
Nevirapine results in decreased expression of CLEC4A3 mRNA
CTD
PMID:23947594
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Clec4m
C-type lectin domain family 4 member M
increases expression
EXP
Nevirapine metabolite results in increased expression of CD209B mRNA
CTD
PMID:23947594
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Cotl1
coactosin-like F-actin binding protein 1
decreases expression
EXP
Nevirapine results in decreased expression of COTL1 mRNA
CTD
PMID:23947594
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
G
Cux2
cut-like homeobox 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of CUX2 mRNA
CTD
PMID:23947594
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
Nevirapine metabolite results in increased expression of CYP2B1 mRNA; Nevirapine results in increased expression of CYP2B1 mRNA
CTD
PMID:23947594
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA
CTD
PMID:17041008
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
affects binding
EXP
Nevirapine binds to CYP2C11 protein
CTD
PMID:22793666
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects binding
ISO
Nevirapine binds to CYP3A4 protein
CTD
PMID:22793666
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
affects binding increases expression
EXP
Nevirapine binds to CYP3A23-3A1 protein Nevirapine results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:22793666 PMID:23947594
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
Nevirapine results in increased expression of CYP3A9 mRNA
CTD
PMID:23947594
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
Nevirapine metabolite results in increased expression of CYP4B1 mRNA
CTD
PMID:23947594
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Dapk1
death associated protein kinase 1
increases expression
EXP
Nevirapine metabolite results in increased expression of DAPK1 mRNA
CTD
PMID:23947594
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dbp
D-box binding PAR bZIP transcription factor
decreases expression
EXP
Nevirapine metabolite results in decreased expression of DBP mRNA
CTD
PMID:23947594
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
Nevirapine results in decreased expression of DDHD1 mRNA
CTD
PMID:23947594
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
G
Dip2a
disco-interacting protein 2 homolog A
increases expression
EXP
Nevirapine results in increased expression of DIP2A mRNA
CTD
PMID:23947594
NCBI chr20:12,284,566...12,371,068
Ensembl chr20:12,284,654...12,370,217
G
Dnajb5
DnaJ heat shock protein family (Hsp40) member B5
increases expression
EXP
Nevirapine metabolite results in increased expression of DNAJB5 mRNA
CTD
PMID:23947594
NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Nevirapine results in increased expression of EDEM1 mRNA
CTD
PMID:23947594
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Egf
epidermal growth factor
decreases expression
ISO
Nevirapine results in decreased expression of EGF mRNA
CTD
PMID:19152342
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
Nevirapine results in decreased expression of EGFR mRNA
CTD
PMID:19152342
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Epb41l3
erythrocyte membrane protein band 4.1-like 3
decreases expression
EXP
Nevirapine results in decreased expression of EPB41L3 mRNA
CTD
PMID:23947594
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
G
Ereg
epiregulin
increases expression
ISO
Nevirapine results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Esm1
endothelial cell-specific molecule 1
increases expression
EXP
Nevirapine metabolite results in increased expression of ESM1 mRNA; Nevirapine results in increased expression of ESM1 mRNA
CTD
PMID:23947594
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Fam107a
family with sequence similarity 107, member A
increases expression
EXP
Nevirapine results in increased expression of FAM107A mRNA
CTD
PMID:23947594
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
G
Fibin
fin bud initiation factor homolog
increases expression
EXP
Nevirapine results in increased expression of FIBIN mRNA
CTD
PMID:23947594
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
Nevirapine metabolite results in increased expression of FKBP5 mRNA; Nevirapine results in increased expression of FKBP5 mRNA
CTD
PMID:23947594
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of FMO1 mRNA
CTD
PMID:23947594
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
EXP
Nevirapine results in increased expression of GADD45B mRNA
CTD
PMID:23947594
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GLUL mRNA
CTD
PMID:23947594
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gsta1
glutathione S-transferase alpha 1
increases glutathionylation
ISO
GSTA1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gstm1
glutathione S-transferase mu 1
increases glutathionylation
ISO
GSTM1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
increases glutathionylation
ISO
GSTP1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gzma
granzyme A
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GZMA mRNA
CTD
PMID:23947594
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
G
Gzmf
granzyme F
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GZMF mRNA
CTD
PMID:23947594
NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HAO2 mRNA; Nevirapine results in decreased expression of HAO2 mRNA
CTD
PMID:23947594
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Hdc
histidine decarboxylase
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HDC mRNA
CTD
PMID:23947594
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hgf
hepatocyte growth factor
decreases secretion
ISO
Nevirapine results in decreased secretion of HGF protein
CTD
PMID:21619898
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
EXP
Nevirapine metabolite results in increased expression of HMGCS2 mRNA; Nevirapine results in increased expression of HMGCS2 mRNA
CTD
PMID:23947594
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases expression
EXP
Nevirapine metabolite results in increased expression of HPGD mRNA
CTD
PMID:23947594
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HSD17B2 mRNA
CTD
PMID:23947594
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Ifng
interferon gamma
increases expression
ISO EXP
Nevirapine results in increased expression of IFNG protein
CTD
PMID:23947594
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igh-6
immunoglobulin heavy chain 6
increases expression
EXP
Nevirapine results in increased expression of IGH-6 mRNA
CTD
PMID:23947594
G
Il1b
interleukin 1 beta
increases expression
ISO
Nevirapine results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il22ra2
interleukin 22 receptor subunit alpha 2
increases expression
EXP
Nevirapine metabolite results in increased expression of IL22RA2 mRNA
CTD
PMID:23947594
NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844
G
Il24
interleukin 24
increases expression
ISO
Nevirapine results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il6
interleukin 6
decreases secretion
ISO
Nevirapine results in decreased secretion of IL6 protein
CTD
PMID:21619898
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbe
inhibin subunit beta E
decreases expression
EXP
Nevirapine metabolite results in decreased expression of INHBE mRNA
CTD
PMID:23947594
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inmt
indolethylamine N-methyltransferase
increases expression
EXP
Nevirapine results in increased expression of INMT mRNA
CTD
PMID:23947594
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Insig2
insulin induced gene 2
increases expression
EXP
Nevirapine results in increased expression of INSIG2 mRNA
CTD
PMID:23947594
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Irgm
immunity-related GTPase M
decreases expression
EXP
Nevirapine results in decreased expression of IRGM mRNA
CTD
PMID:23947594
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
EXP
Nevirapine results in increased expression of ITPR1 mRNA
CTD
PMID:23947594
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Klf15
KLF transcription factor 15
increases expression
EXP
Nevirapine metabolite results in increased expression of KLF15 mRNA
CTD
PMID:23947594
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
Nevirapine results in increased expression of KLK3 mRNA; Nevirapine results in increased expression of KLK3 protein
CTD
PMID:19152342
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Krt18
keratin 18
increases expression
ISO
Nevirapine results in increased expression of KRT18 protein
CTD
PMID:19152342
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt23
keratin 23
increases expression
EXP
Nevirapine metabolite results in increased expression of KRT23 mRNA
CTD
PMID:23947594
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
G
Lcat
lecithin cholesterol acyltransferase
increases expression
ISO
Nevirapine results in increased expression of LCAT protein
CTD
PMID:19667106
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Ldaf1
lipid droplet assembly factor 1
decreases expression
EXP
Nevirapine results in decreased expression of LDAF1 mRNA
CTD
PMID:23947594
NCBI chr 1:174,484,438...174,503,037
Ensembl chr 1:174,484,447...174,503,036
G
Lep
leptin
increases expression
ISO
Nevirapine results in increased expression of LEP mRNA
CTD
PMID:21619898
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lifr
LIF receptor subunit alpha
increases expression
EXP
Nevirapine metabolite results in increased expression of LIFR mRNA
CTD
PMID:23947594
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lipg
lipase G, endothelial type
decreases expression
EXP
Nevirapine metabolite results in decreased expression of LIPG mRNA; Nevirapine results in decreased expression of LIPG mRNA
CTD
PMID:23947594
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lpin1
lipin 1
increases expression
EXP
Nevirapine metabolite results in increased expression of LPIN1 mRNA
CTD
PMID:23947594
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpl
lipoprotein lipase
increases expression
ISO
Nevirapine results in increased expression of LPL mRNA
CTD
PMID:21619898
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
increases expression
EXP
Nevirapine metabolite results in increased expression of LRG1 mRNA
CTD
PMID:23947594
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Ly86
lymphocyte antigen 86
decreases expression
EXP
Nevirapine results in decreased expression of LY86 mRNA
CTD
PMID:23947594
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
G
Meox2
mesenchyme homeobox 2
increases expression
EXP
Nevirapine results in increased expression of MEOX2 mRNA
CTD
PMID:23947594
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Nevirapine results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mgp
matrix Gla protein
increases expression
EXP
Nevirapine results in increased expression of MGP mRNA
CTD
PMID:23947594
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mrc1
mannose receptor, C type 1
increases expression
EXP
Nevirapine metabolite results in increased expression of MRC1 mRNA
CTD
PMID:23947594
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Ms4a7
membrane spanning 4-domains A7
decreases expression
EXP
Nevirapine results in decreased expression of MS4A7 mRNA
CTD
PMID:23947594
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
Nevirapine metabolite results in increased expression of NAMPT mRNA
CTD
PMID:23947594
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
increases expression
EXP
Nevirapine results in increased expression of NDUFAF4 mRNA
CTD
PMID:23947594
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
G
Nlrc5
NLR family, CARD domain containing 5
increases expression
ISO
Nevirapine results in increased expression of NLRC5
CTD
PMID:26626330
NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
G
Npas2
neuronal PAS domain protein 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NPAS2 mRNA; Nevirapine results in decreased expression of NPAS2 mRNA
CTD
PMID:23947594
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Nptx2
neuronal pentraxin 2
increases expression
EXP
Nevirapine results in increased expression of NPTX2 mRNA
CTD
PMID:23947594
NCBI chr12:10,037,435...10,048,345
Ensembl chr12:10,037,435...10,048,345
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NR1D1 mRNA
CTD
PMID:23947594
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
[Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA
CTD
PMID:17041008
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NREP mRNA; Nevirapine results in decreased expression of NREP mRNA
CTD
PMID:23947594
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
P2rx7
purinergic receptor P2X 7
decreases expression
EXP
Nevirapine results in decreased expression of P2RX7 mRNA
CTD
PMID:23947594
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
Pcp4l1
Purkinje cell protein 4-like 1
decreases expression
EXP
Nevirapine results in decreased expression of PCP4L1 mRNA
CTD
PMID:23947594
NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression
EXP
Nevirapine metabolite results in increased expression of PDK4 mRNA
CTD
PMID:23947594
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Nevirapine results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
EXP
Nevirapine results in increased expression of PIK3IP1 mRNA
CTD
PMID:23947594
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
G
Pir
pirin
increases expression
EXP
Nevirapine metabolite results in increased expression of PIR mRNA
CTD
PMID:23947594
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pira2
paired-Ig-like receptor A2
decreases expression
EXP
Nevirapine results in decreased expression of PIRA2 mRNA
CTD
PMID:23947594
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
EXP
Nevirapine metabolite results in increased expression of PNPLA2 mRNA
CTD
PMID:23947594
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP
Nevirapine metabolite results in increased expression of POR mRNA; Nevirapine results in increased expression of POR mRNA
CTD
PMID:23947594
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
Nevirapine results in increased expression of PPARG mRNA
CTD
PMID:21619898
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp2r2b
protein phosphatase 2, regulatory subunit B, beta
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PPP2R2B mRNA; Nevirapine results in decreased expression of PPP2R2B mRNA
CTD
PMID:23947594
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
G
Prf1
perforin 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PRF1 mRNA
CTD
PMID:23947594
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Pycr1
pyrroline-5-carboxylate reductase 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PYCR1 mRNA
CTD
PMID:23947594
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Rbm3
RNA binding motif protein 3
increases expression
EXP
Nevirapine results in increased expression of RBM3 mRNA
CTD
PMID:23947594
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Nevirapine metabolite results in increased expression of RETREG1 mRNA; Nevirapine results in increased expression of RETREG1 mRNA
CTD
PMID:23947594
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
G
Rhbdd2
rhomboid domain containing 2
increases expression
EXP
Nevirapine results in increased expression of RHBDD2 mRNA
CTD
PMID:23947594
NCBI chr12:21,043,605...21,054,305
Ensembl chr12:21,043,608...21,054,289
G
Rprm
reprimo, TP53 dependent G2 arrest mediator homolog
decreases expression
EXP
Nevirapine metabolite results in decreased expression of RPRM mRNA
CTD
PMID:23947594
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
G
S100a7a
S100 calcium binding protein A7A
increases expression
EXP
Nevirapine metabolite results in increased expression of S100A7A mRNA
CTD
PMID:23947594
NCBI chr 2:176,151,405...176,155,846
Ensembl chr 2:176,151,288...176,156,441
G
Scp2
sterol carrier protein 2
increases expression
ISO
Nevirapine results in increased expression of SCP2
CTD
PMID:26626330
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Slamf9
SLAM family member 9
decreases expression
EXP
Nevirapine results in decreased expression of SLAMF9 mRNA
CTD
PMID:23947594
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of SLC34A2 mRNA
CTD
PMID:23947594
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc5a5
solute carrier family 5 member 5
multiple interactions
ISO
[Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein
CTD
PMID:16030158
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Nevirapine results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression decreases expression
ISO EXP
Nevirapine results in increased expression of SREBF1 mRNA Nevirapine metabolite results in decreased expression of SREBF1 mRNA
CTD
PMID:21619898 PMID:23947594
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sult1a1
sulfotransferase family 1A member 1
increases activity
EXP
Nevirapine metabolite results in increased activity of SULT1A1 protein; Nevirapine results in increased activity of SULT1A1 protein
CTD
PMID:27417440
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tg
thyroglobulin
increases expression
ISO
Nevirapine results in increased expression of TG mRNA; Nevirapine results in increased expression of TG protein
CTD
PMID:16030158
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
G
Tmem64
transmembrane protein 64
increases expression
EXP
Nevirapine metabolite results in increased expression of TMEM64 mRNA; Nevirapine results in increased expression of TMEM64 mRNA
CTD
PMID:23947594
NCBI chr 5:28,698,947...28,745,384
Ensembl chr 5:28,698,918...28,745,330
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Nevirapine results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tox3
TOX high mobility group box family member 3
increases expression
EXP
Nevirapine results in increased expression of TOX3 mRNA
CTD
PMID:23947594
NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148
G
Tpo
thyroid peroxidase
increases expression
ISO
Nevirapine results in increased expression of TPO mRNA; Nevirapine results in increased expression of TPO protein
CTD
PMID:16030158
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Trim24
tripartite motif-containing 24
decreases expression
EXP
Nevirapine results in decreased expression of TRIM24 mRNA
CTD
PMID:23947594
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Trim63
tripartite motif containing 63
increases expression
EXP
Nevirapine metabolite results in increased expression of TRIM63 mRNA
CTD
PMID:23947594
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Tsc22d3
TSC22 domain family, member 3
increases expression
EXP
Nevirapine results in increased expression of TSC22D3 mRNA
CTD
PMID:23947594
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions
ISO
[Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein; Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]]
CTD
PMID:16030158
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tshr
thyroid stimulating hormone receptor
increases expression
ISO
Nevirapine results in increased expression of TSHR mRNA
CTD
PMID:16030158
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
EXP
Nevirapine results in increased expression of TSKU mRNA
CTD
PMID:23947594
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Ucp1
uncoupling protein 1
increases expression
ISO
Nevirapine results in increased expression of UCP1
CTD
PMID:16038477
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Ucp3
uncoupling protein 3
increases expression
EXP
Nevirapine metabolite results in increased expression of UCP3 mRNA
CTD
PMID:23947594
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Nevirapine metabolite results in increased expression of VCAM1 mRNA
CTD
PMID:23947594
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
Nevirapine results in decreased expression of VEGFA mRNA
CTD
PMID:19152342
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vsnl1
visinin-like 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of VSNL1 mRNA; Nevirapine results in decreased expression of VSNL1 mRNA
CTD
PMID:23947594
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
increases expression
EXP
Nevirapine results in increased expression of ZAP70 mRNA
CTD
PMID:23947594
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all